Magnesium sulfate is one of the most widely used medications in hospital settings, prescribed for conditions ranging from preeclampsia and eclampsia to severe asthma and certain heart rhythm disturbances. Its side effects span a wide range, from the merely uncomfortable (flushing, warmth, nausea) to the genuinely dangerous (respiratory depression, cardiac conduction changes, and loss of protective reflexes). The severity depends heavily on how the drug is given, how much accumulates in the blood, and how well the kidneys can clear it. What makes magnesium sulfate tricky is that its therapeutic window is narrow, so the line between a helpful dose and a harmful one is thinner than many patients and even some clinicians expect.
The Common, Uncomfortable Side Effects
Most people who receive intravenous magnesium sulfate notice something almost immediately. Flushing, a sensation of warmth spreading through the face and chest, and sometimes a feeling of heaviness or fatigue are among the most frequently reported experiences. In children treated for acute asthma, minor side effects include facial warmth, flushing, pain or numbness at the infusion site, dry mouth, and general malaise.1PubMed Central. Magnesium for treatment of asthma in children Adults describe similar symptoms. Nausea and a drop in blood pressure are also common, though in pediatric asthma trials actual hypotension requiring intervention has been uncommon.2PubMed Central. Pharmacokinetics and Pharmacodynamics of Intravenous Magnesium Sulfate in Pediatric Acute Asthma Exacerbations
These mild effects tend to be dose-related and usually fade once the infusion slows or stops. They are annoying but not dangerous on their own. The real concern with magnesium sulfate is what happens when blood levels climb higher than intended.
Neuromuscular Effects and the Patellar Reflex Check
One of the earliest warning signs that magnesium levels are getting too high is the loss of deep tendon reflexes, particularly the knee-jerk (patellar) reflex. This is why clinicians treating preeclamptic patients on magnesium drips check the patellar reflex repeatedly, sometimes every hour. If you tap the knee and get no response, the magnesium level may be approaching a dangerous range.
In a large integrative review that aggregated data from over 9,500 women receiving magnesium sulfate for preeclampsia or eclampsia, about 1.6% had absent patellar reflexes, though individual studies reported rates as high as 57%.3PubMed Central. An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management That huge range reflects differences in dosing protocols, monitoring frequency, and study design. But even the overall rate of 1.6% represents a meaningful number of women whose reflexes disappeared during treatment. Because reflex loss precedes more dangerous toxicity, its absence is used as the practical bedside signal to pause or reduce the infusion.
Respiratory Depression
This is the side effect that keeps clinicians up at night. At very high magnesium levels, the muscles involved in breathing can weaken to the point that a patient cannot maintain adequate ventilation. In the same large review of preeclampsia patients, the overall rate of respiratory depression was about 1.3%, with individual studies reporting rates up to roughly 8%.4PubMed Central. An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management
Respiratory depression from magnesium can be especially insidious in surgical patients. In one reported case, a patient who received an intravenous bolus of magnesium sulfate during cardiac surgery to treat a fast heart rhythm developed severe respiratory depression that prevented weaning from the ventilator afterward. The signs of high magnesium are nonspecific, so the connection was not immediately obvious. The patient also had early-stage kidney disease, which slowed magnesium clearance.5PubMed Central. Postoperative respiratory depression caused by iatrogenic hypermagnesaemia That case highlights how easily magnesium toxicity can be missed when clinicians are not specifically looking for it.
What Happens to the Heart
Magnesium sulfate has real effects on the heart’s electrical system. In a study of human subjects, magnesium infusion slowed conduction through the atrioventricular (AV) node, the structure that relays electrical signals between the upper and lower chambers of the heart. The time it took signals to travel through the AV node increased significantly, and the threshold at which the AV node started to block signals dropped. Magnesium also prolonged sinus node recovery time, meaning the heart’s natural pacemaker took longer to reset after stimulation.6PubMed. Effects of magnesium sulfate on cardiac conduction and refractoriness in humans
In plain terms, magnesium makes the heart’s electrical system sluggish. At therapeutic doses this is sometimes the whole point: slowing down a dangerously fast rhythm. But at excessive levels, it can cause the heart to beat too slowly or develop conduction blocks. At extremely high concentrations, cardiac arrest becomes a risk. This is why heart rate and blood pressure monitoring are standard whenever magnesium sulfate is being infused.
Metabolic Disruptions, Especially Calcium
One of the less intuitive side effects of magnesium sulfate is that it can drive blood calcium levels dangerously low. This happens through at least two pathways. First, high magnesium levels suppress the parathyroid glands, which are responsible for maintaining calcium balance. In a study of human subjects receiving magnesium infusions, parathyroid hormone (PTH) levels dropped rapidly and remained depressed for two hours, even as calcium levels were falling. The researchers concluded that the hypocalcemia seen during magnesium infusion is partly caused by this suppression of PTH.7PubMed. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects
Second, high magnesium increases urinary calcium excretion, essentially flushing calcium out through the kidneys.8PubMed Central. Hypocalcemia and hyperkalemia during magnesium infusion therapy in a pre-eclamptic patient The combination of suppressed PTH and increased calcium loss can produce symptomatic hypocalcemia, with muscle cramps, tingling, and in severe cases, seizures or cardiac rhythm changes. In one reported case, a woman being treated for toxemia of pregnancy developed severe hypocalcemia with a low PTH level directly attributable to the magnesium sulfate she was receiving.9PubMed. Hypocalcemia after therapeutic use of magnesium sulfate
There is an irony here: calcium gluconate is the standard antidote for magnesium toxicity. It works by counteracting the neuromuscular blockade that excess magnesium causes. So the same electrolyte that magnesium suppresses is also the one used to rescue patients from magnesium overdose.
Why Kidney Function Matters So Much
Magnesium is cleared almost entirely by the kidneys. About 90% of an intravenous dose is excreted in the urine within the first 24 hours.10PubMed. Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles This means that anyone with impaired kidney function is at dramatically higher risk for toxicity, because the drug simply accumulates faster than the body can get rid of it. Magnesium toxicity occurs most often in patients with decreased kidney function or in preeclamptic patients receiving high-dose therapy.11PubMed Central. Magnesium sulfate toxicity successfully managed with hemodialysis: a case report
In severe cases of magnesium toxicity where calcium gluconate is not enough and the kidneys cannot clear the magnesium, hemodialysis can be used to rapidly pull magnesium out of the blood. This is rare but lifesaving when it is needed. For patients with known kidney problems who require magnesium sulfate, dosing protocols are typically adjusted downward, and monitoring is more frequent. The standard clinical approach includes checking urine output alongside reflexes and respiratory rate. If urine output drops, magnesium accumulation becomes a real concern.
Fluid Overload and Pulmonary Edema
When magnesium sulfate is given as a continuous drip, especially for extended periods, the sheer volume of intravenous fluid can become a problem in its own right. Pulmonary edema, where fluid accumulates in the lungs and makes breathing difficult, is a recognized complication. Risk factors include higher infusion rates of both magnesium and accompanying intravenous fluids, less concentrated magnesium solutions (which require more total fluid volume), infection, carrying more than one baby, receiving other medications to stop preterm labor at the same time, and having a large positive net fluid balance overall.12American Journal of Obstetrics & Gynecology. Risk factors for the development of pulmonary edema during magnesium sulfate tocolysis
This is a complication of the treatment protocol as much as the drug itself, but it is important to understand because it can be mistaken for worsening of the underlying condition rather than a side effect of therapy. Careful fluid tracking is one of the less glamorous but most important parts of managing a patient on a magnesium drip.
Drug Interactions That Amplify Risk
Magnesium sulfate does not exist in a vacuum. Many patients receiving it are also on other medications, and some combinations are genuinely hazardous. The most well-documented dangerous interaction is with calcium channel blockers such as nifedipine. Both drugs relax smooth muscle and suppress cardiac function, and together they can produce neuromuscular blockade at magnesium doses far below what would normally cause trouble. In one case, a patient developed complete neuromuscular blockade after receiving just 500 mg of magnesium sulfate while also taking nifedipine for tocolysis (stopping preterm contractions).13American Journal of Obstetrics & Gynecology. Neuromuscular blockade and nifedipine That is a tiny dose; the standard loading dose for preeclampsia is typically 4 to 6 grams.
A broader analysis of the risks associated with calcium channel blockers confirmed this synergistic depression of cardiac function when these drugs are combined with magnesium sulfate, and recommended that the combination be used with great caution.14PubMed. Analysis of the risks associated with calcium channel blockade: implications for the obstetrician-gynecologist Other drug classes that can amplify magnesium’s effects include aminoglycoside antibiotics and other neuromuscular blocking agents, though the evidence base for these interactions is smaller.
Effects on Newborns When Mothers Receive Magnesium
Magnesium readily crosses the placenta, so when a pregnant woman receives magnesium sulfate, her baby is exposed too. The most consistent neonatal finding is temporary hypotonia, a kind of floppiness in the newborn. In a prospective controlled study, infants exposed to magnesium sulfate in utero had a higher incidence of hypotonia and lower Apgar scores at birth compared to unexposed infants.15PubMed. The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study A separate study found higher rates of NICU admission and hypotonia among neonates whose mothers received magnesium sulfate in late preterm and term pregnancies.16PubMed Central. Neonatal Effects of Maternal Magnesium Sulphate in Late Preterm and Term Pregnancies
However, a larger analysis of over 1,000 patients found that magnesium exposure did not increase the risk of needing neonatal resuscitation or other short-term adverse outcomes.17PubMed. Does magnesium exposure affect neonatal resuscitation? The picture that emerges is one of a transient effect: exposed babies may look floppier initially and score lower on early assessments, but serious lasting harm is uncommon in the short term.
Bone Effects in Babies After Prolonged Maternal Use
A more concerning neonatal side effect emerges with prolonged maternal magnesium therapy, specifically effects on the baby’s bones. In a case report involving triplets whose mother received intravenous magnesium sulfate continuously from 22 to 30 weeks of gestation, two surviving infants developed severe bone loss and multiple fractures by 20 days of age.18PubMed. Skeletal demineralization and fractures caused by fetal magnesium toxicity Research on the mechanism has shown that neonates born after prolonged maternal magnesium use had significantly lower blood calcium levels and higher levels of an enzyme that serves as a marker for bone turnover. Radiographic bone abnormalities were found in some of these infants, though by three weeks of age the marker levels had normalized.19PubMed. Prolonged maternal magnesium administration and bone metabolism in neonates
This generated significant concern, and in 2013 the FDA issued a safety communication about potential fetal harm from prolonged magnesium sulfate use. However, a population-level study of over 4,000 pregnancies later found no statistically significant increase in infant fracture risk associated with prolonged magnesium sulfate tocolysis, even at higher doses or longer treatment durations.20PubMed Central. Association between the prolonged use of magnesium sulfate for tocolysis and fracture risk among infants The discrepancy likely reflects the difference between dramatic case reports involving extreme exposure (eight continuous weeks, in the triplet case) and the shorter courses most patients actually receive. The bone effects appear to be a real phenomenon at extreme durations but not a significant risk at typical treatment lengths.
Oral Magnesium Sulfate Is a Different Story
Everything discussed so far primarily applies to intravenous magnesium sulfate used in hospital settings. Oral magnesium sulfate, known to most people as Epsom salt, behaves differently. When swallowed, magnesium sulfate acts as an osmotic laxative, pulling water into the intestines. Diarrhea is essentially the expected effect, not a side effect, when people take it as a cathartic. In a study of oral magnesium sulfate absorption, all subjects experienced mild or moderate diarrhea, and the investigators warned that use in patients with impaired kidneys can lead to severe toxicity because enough magnesium gets absorbed to cause dangerously high blood levels.21PubMed. Absorption of magnesium from orally administered magnesium sulfate in man
For people taking magnesium supplements in other forms (magnesium oxide, citrate, glycinate, and so on), the gastrointestinal picture is milder. A review that examined multiple studies and a federal adverse-event database found that diarrhea from magnesium supplements is less common than widely assumed. Among studies testing supplemental doses up to 1,200 mg per day, most found no significant difference in diarrhea between supplemented and placebo groups. Out of only 40 attributable gastrointestinal complaints in the federal database for single-ingredient magnesium products, just about a third mentioned diarrhea.22PubMed Central. Perspective: Call for Re-evaluation of the Tolerable Upper Intake Level for Magnesium Supplementation in Adults This suggests the common belief that any magnesium supplement will cause loose stools is overstated, though magnesium sulfate specifically remains among the more gut-disrupting forms.
How Magnesium Toxicity Is Treated
The standard first-line response to magnesium sulfate toxicity is intravenous calcium gluconate. Calcium directly opposes many of magnesium’s effects on nerve and muscle cells, so it can rapidly reverse neuromuscular blockade and improve cardiac conduction even while blood magnesium remains elevated. In the large review of preeclampsia studies, calcium gluconate was administered in less than 0.2% of cases, and there was only one maternal death attributed to magnesium sulfate among over 9,500 women studied.23PubMed Central. An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management
When calcium alone is not sufficient, or when kidney function is too poor to clear the magnesium, hemodialysis becomes the definitive treatment. This is a last resort but an effective one. The treatment ladder, then, runs from the simplest intervention (stop the infusion, give calcium, support breathing) to the most aggressive (dialysis). In practice, most cases of toxicity are caught early through reflex and respiratory monitoring and resolve simply by stopping or slowing the drip.
Magnesium Sulfate for Childhood Asthma
Outside of obstetrics, one of the growing uses of intravenous magnesium sulfate is in children with severe asthma attacks who are not responding to standard bronchodilators. The side-effect profile in this context tends to be milder because the doses are lower and the treatment is usually a single bolus rather than a prolonged infusion. In pediatric asthma trials, reported side effects have been largely limited to warmth, flushing, and discomfort at the infusion site.24PubMed Central. Magnesium for treatment of asthma in children In a pharmacokinetic study of 31 children receiving intravenous magnesium for acute asthma exacerbations, only two developed hypotension, and there was no clear relationship between blood magnesium concentration and the occurrence of low blood pressure.25PubMed Central. Pharmacokinetics and Pharmacodynamics of Intravenous Magnesium Sulfate in Pediatric Acute Asthma Exacerbations For children with healthy kidneys receiving short courses, the risk profile is considerably more favorable than for preeclamptic women on prolonged high-dose infusions.